Press Contact

If you need further information, would like to interview ilS or have any other proposal, please contact

ils@ilsintelligence.com

Contact Us

If you have any questions or want to know more about ilS, please fill the form below or send us an email to: info.es@ilsintelligence.com

I accept the Privacy Policy



Check our latest news
  • ilS Newsletter - June 2017

    Look at our latest Newsletter.

  • ilS Newsletter - January 2017

    Look at our latest Newsletter

  • ilS celebrated its Second Edition of the ilS Speaker Series(SM)

    The Second Edition of ilS Speaker SeriesSM, which was focused on Rare Diseases, was celebrated last Friday April 27th in Madrid. Under the tilte: "Orphan Drugs: How to Speed Up their Access to Patients with Rare Diseases?" ilS Speaker Series laid the grounds to discuss about the patient and market needs in regards to Rare Diseases and Orphan Drugs.

  • ilS presents the Second Edition of ilS Speaker Series(SM) focused this year on Rare Diseases

    Although Rare Diseases are those that affect a small number of the population (5 out of 10,000 inhabitants), only in Spain there are more than 3 million people affected by this condition. For that reason ilS has decided to focus the Second Edition of its ilS Speaker SeriesSM on this subject.

  • ilS Newsletter - January 2015

    Look at our latest Newsletter.

  • ilS Specialist in Primary Studies

    Insights in Life Sciences (ilS) is a consultancy firm with broad experience in performing Primary Studies with globally renowned experts in the Life Sciences field. In contrast to Secondary Studies, to perform Primary Studies the source of knowledge is directly accessed first-hand by means of in-depth telephone interviews, online surveys or on-site advisory boards or focus groups. ilS is specialized in the use of the different existing techniques needed to perform such studies.


See all news



join_us

Join our expert network

If you are interested in joining our global Life Sciences expert network, please send an email to ilS@ilsintelligence.com